Wednesday, December 7, 2016

BRIEF-Aclaris initiates phase 1 clinical trial for ati-50001

* Trial is being conducted in 12 healthy volunteers to

evaluate safety, bioavailability, and pharmacodynamics of

ATI-50001

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)